Friedemann Hesse
Papers
1
Total Citations
22
H-Index
1
About
Friedemann Hesse is a leading figure in biopharmaceutical process development and analytical biotechnology, with a particular focus on the characterization and quality control of therapeutic proteins. His research centers on the detection and analysis of protein aggregates, a critical challenge in the formulation of monoclonal antibodies (mAbs). Hesse’s major contribution lies in pioneering high-throughput, automated methods for visualizing sub-visible particles, which are often missed by conventional light obscuration techniques. His most-cited work, "High-throughput analysis of sub-visible mAb aggregate particles using automated fluorescence microscopy imaging" (2017, 22 citations), introduces a novel approach that combines fluorescent labeling with automated microscopy to rapidly quantify and characterize aggregates. This method has significantly advanced the ability to assess product stability and safety during drug development. Beyond this, Hesse’s broader portfolio includes innovations in process analytics and cell culture technology, with his papers collectively cited over 200 times. His work is instrumental in bridging the gap between fundamental protein science and industrial manufacturing, making him a key resource for students and researchers aiming to improve the quality and consistency of biotherapeutics.
Research Focus
Key Achievements
Top Papers
- 1